Indaba Capital Management »

Merrimack Pharma shares owned by Indaba Capital Management

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Indaba Capital Management from 13F filings

Historical chart of Indaba Capital Management investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Indaba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Indaba Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 224k 13.41
2023-09-30 $1.7M 137k 12.33

More positions owned by Indaba Capital Management

Standard Biotools Note 5.250%12/0 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
On24 (ONTF)
Snap One Holdings Corp (SNPO)
D Fluidigm Corp Del (LAB)
Accelerate Diagnostics Note 5.000%12/1 (Principal)
Merrimack Pharmaceuticals In Com New (MACK)
Owl Rock Capital Corporation (OBDC)
Holley *w Exp 11/30/202 (HLLY.WS)

View all positions for Indaba Capital Management

Top funds holding Merrimack Pharma

Western Standard
Newtyn Management
Vanguard Group
Madison Avenue Partners
ADAR1 Capital Management
Dimensional Fund Advisors
Sepio Capital
Indaba Capital Management
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Merrimack Pharma